Jack W. Callicutt - Chief Financial Officer at Galectin Therapeutics Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
GALT on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Jack W. Callicutt - trading volume in the past year for Galectin Therapeutics Inc

Holdings reported by Jack W. Callicutt for Galectin Therapeutics Inc

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Unit 60K $69.6K $1.16 Jan 23, 2025 Direct Common Stock
Common stock 7.61K $47.4K $6.22 Nov 18, 2025 Direct
Commno stock 7.61K $45.8K $6.01 Nov 3, 2025 Direct
Restricted Stock Units 0 $0 $0.82 Dec 23, 2024 Direct Common Stock
Stock option (right to buy) 0 $0 $1.37 Nov 18, 2025 Direct Common stock
Common stock (right to buy) 0 Nov 18, 2025 Direct Common stock

Transactions reported by Jack W. Callicutt for Galectin Therapeutics Inc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.